First Turn Management’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
First Turn Management's SMMT Position: Q3 2026 in Review
First Turn Management opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 501,724 shares worth $8.48M. The stake represents 1.13% of the portfolio and ranks #35 among its holdings.
296 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- First Turn Management held 501,724 shares of Summit Therapeutics worth $8.48M as of Q3 2026.
- Summit Therapeutics was a new First Turn Management position in Q3 2026.
- Summit Therapeutics made up 1.13% of First Turn Management's portfolio in Q3 2026, its #35 holding.
- 296 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on First Turn Management's 13F filing for Q3 2026, filed 16 Nov 2026.